Orient Tradelink Limited has provided an explanation for the delay in submitting its financial results for the quarter ended September 30, 2025. The company disclosed this information in a regulatory filing to the Bombay Stock Exchange (BSE) on December 5, 2025.

Reasons for Delay

The company cited several factors that contributed to the postponement of its Board Meeting and the subsequent delay in submitting the Q2 FY26 financial results:

1. Initial Postponements: The Board Meeting, originally scheduled for November 14, 2025, was adjourned twice - first to November 19, and then to November 21, 2025.

2. Financial Discrepancies: The company identified mismatches in some financial figures, necessitating additional review time.

3. Auditor Review: The statutory auditors required more time to review and reconcile the differences in the financial data.

Timeline of Events

Company's Statement

Orient Tradelink Limited emphasized that the delay was unintentional and not a result of any deliberate or willful lapse. The company acknowledged an inadvertent delay in disclosing the detailed reasons for the late submission to the Stock Exchange but reaffirmed its commitment to full regulatory compliance.

Regulatory Implications

The company's explanation comes in response to a BSE email dated December 4, 2025, regarding non-disclosure of reasons for the delay in submitting financial results as per Regulation 33 of SEBI (LODR) Regulations, 2015.

Timely submission of financial results is a crucial aspect of corporate governance and regulatory compliance. Investors and regulatory bodies closely monitor such delays as they can impact market transparency and investor decision-making.

Orient Tradelink Limited's proactive disclosure of the reasons for the delay demonstrates its efforts to maintain transparency with its stakeholders.

Orient Tradelink Limited has announced the allotment of 1,00,000 new equity shares through warrant conversion, as approved by its Board of Directors in a meeting held on December 10, 2025. This corporate action represents a strategic expansion of the company's equity base and demonstrates continued promoter participation in the company's growth.

Share Allotment Details

The Board approved the allotment of equity shares following the exercise of conversion options by the warrant holder. The key parameters of this allotment are outlined below:

Impact on Share Capital Structure

The allotment has resulted in a significant increase in the company's paid-up share capital. The updated capital structure reflects the company's expanded equity base:

Regulatory Compliance and Approvals

The warrant conversion was executed in accordance with Chapter V of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The company had received in-principle approval from BSE Limited on April 1, 2025, for this conversion process. The warrants were originally allotted to Chattar Singh on April 11, 2025. The allotment represents 75% of the warrant issue price as balance subscription amount at ₹12.00 per warrant.

Shareholding Pattern Impact

Following the allotment, the shareholding pattern shows minimal change in percentage terms due to the relatively small size of the allotment compared to the total share base:

The Board meeting commenced at 1:30 PM and concluded at 2:00 PM on December 10, 2025, with the allotment being one of the key agenda items approved during the session. The company has informed BSE Limited about this development under Regulation 30 of SEBI (LODR) Regulations, 2015.